Pharmaceutical Radiochemistry, Technische Universität München, Walther-Meißner-Strasse 3, 85748 Garching, Germany.
ChemMedChem. 2013 Jan;8(1):95-103. doi: 10.1002/cmdc.201200471. Epub 2012 Nov 7.
To assess the influence of Zn(2+) , Cu(2+) , Fe(3+) , Al(3+) , Ti(IV) , and Sn(IV) on incorporation of (68) Ga(3+) into pendant-arm macrocyclic chelators, the (68) Ga labeling of 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), 1,4,7-triazacyclononane-1,4,7-tris[methyl(2-carboxyethyl)phosphinic acid]) (TRAP), and 1,4,7-triazacyclononane-1-[methyl(2-carboxyethyl)phosphinic acid]-4,7-bis[methyl(2-hydroxymethyl)phosphinic acid] (NOPO), as well as their peptide conjugates, was investigated in the presence of varying concentrations of these metal ions. The (68) Ga labeling yield for carboxylate-type chelators NOTA and DOTA is decreased at lower metal ion contaminant concentrations compared with phosphinate-type chelators TRAP and NOPO. The latter are able to rapidly exchange coordinated Zn(II) with (68) Ga(3+) , as confirmed by mass spectrometry and (31) P NMR spectroscopy. (68) Ga labeling of Zn(II) complexes of TRAP and NOPO proceeds as efficient as labeling of neat NOTA; this applies also to the corresponding peptide conjugates of these chelators. This behavior results in substantially improved selectivity for Ga(3+) and, therefore, in more robust and reliable (68) Ga labeling procedures. In addition, none of the investigated chelators binds (68) Ge, rendering post-labeling purification protocols, for example, solid-phase extraction, a reliable means of removal of (68) Ge contamination from (68) Ga radiopharmaceuticals.
为了评估 Zn(2+)、Cu(2+)、Fe(3+)、Al(3+)、Ti(IV)和 Sn(IV)对(68)Ga(3+)结合到悬垂臂大环螯合剂中的影响,研究了(68)Ga 标记 1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA)、1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)、1,4,7-三氮杂环壬烷-1,4,7-三[甲基(2-羧乙基)膦酸](TRAP)和 1,4,7-三氮杂环壬烷-1-[甲基(2-羧乙基)膦酸]-4,7-双[甲基(2-羟甲基)膦酸](NOPO)及其肽缀合物的过程,其中存在不同浓度的这些金属离子。与膦酸盐型螯合剂 TRAP 和 NOPO 相比,较低的金属离子污染物浓度会降低羧酸型螯合剂 NOTA 和 DOTA 的(68)Ga 标记产率。后两者能够快速将配位的 Zn(II)与(68)Ga(3+)交换,这通过质谱和(31)P NMR 光谱得到证实。TRAP 和 NOPO 的 Zn(II)配合物的(68)Ga 标记效率与标记纯 NOTA 一样高效;这也适用于这些螯合剂的相应肽缀合物。这种行为导致 Ga(3+)的选择性大大提高,因此,(68)Ga 标记程序更稳健、更可靠。此外,没有一种螯合剂与(68)Ge 结合,这使得例如固相萃取的放射性药物后标记纯化方案成为从(68)Ga 放射性药物中去除(68)Ge 污染的可靠手段。